qqueue believes that the FDA could have in issue w/the A1c reductions in trial 171. I was wondering what were everyone else's thoughts? I really was hoping for more conclusive results, so didn't have to worry about letting my shares ride into the FDA submission.

I'm curious what everyone's else's opinion is in regards to the uresults. I know reading Rapps' rap over at yahoo makes me a little nervous.

Still holding wayy too many shares. Actually bought 5k more today. Not because of my confidence in the results, but more because I am a gambler. Hoping for some positive comments to make me feel better about my investment. I am definitely not a biotech expert.